Elise Sverre (E Sverre)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Aortic Stenosis

Clinical Practice

Cardiovascular Events

Top Venues

BMC cardiovascular disorders

European heart journal. Cardiovascular pharmacotherapy

Sleep advances : a journal of the Sleep Research Society

Scandinavian cardiovascular journal : SCJ

This page only lists publications with an associated author ORCID identifier.

Publications

Jonas Pivoriunas, Nils Tore Vethe, Einar Husebye, Morten Wang Fagerland, Stein Bergan, Oscar Kristiansen, John Munkhaugen Prof, Elise Sverre
Validation of a novel direct method to determine reduced adherence to atorvastatin therapy. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Jonas Pivoriunas, Nils Tore Vethe, Einar Husebye, Morten Wang Fagerland, Stein Bergan, Oscar Kristiansen, John Munkhaugen Prof, Elise Sverre
Validation of a novel direct method to determine reduced adherence to atorvastatin therapy. European heart journal. Cardiovascular pharmacotherapy (2024)
Elise Sverre, J Munkhaugen, Oscar Kristiansen, H Weedon-Fekjaer, K Peersen, E Gjertsen, L Gullestad, S Bergan, E Husebye, Nils Tore Vethe
Plasma concentration of atorvastatin metabolites correlates with low-density lipoprotein cholesterol reduction in patients with coronary heart disease. Pharmacology research & perspectives 11 (3) (2023)
Lars Aastebøl Frøjd, Toril Dammen, John Munkhaugen, Harald Weedon-Fekjær, Inger Hilde Nordhus, Costas Papageorgiou, Elise Sverre
Insomnia as a predictor of recurrent cardiovascular events in patients with coronary heart disease. Sleep advances : a journal of the Sleep Research Society 3 (1) (2022)
Lars Aastebøl Frøjd, Toril Dammen, John Munkhaugen, Harald Weedon-Fekjær, Inger Hilde Nordhus, Costas Papageorgiou, Elise Sverre
Insomnia as a predictor of recurrent cardiovascular events in patients with coronary heart disease. Sleep advances : a journal of the Sleep Research Society 3 (1) (2022)
Elise Sverre, Kari Peersen, Oscar Kristiansen, Morten W Fagerland, Joep Perk, Einar Husebye, Nils Tore Vethe, Toril Dammen, John Munkhaugen Prof
Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self-perceived muscle side effects. Journal of internal medicine 291 (6) (2022)
Oscar Kristiansen, Nils Tore Vethe, Kari Peersen, Morten Wang Fagerland, Elise Sverre, Elena Prunés Jensen, Morten Lindberg, Erik Gjertsen, Lars Gullestad, Joep Perk, Toril Dammen, Stein Bergan, Einar Husebye, Jan Erik Otterstad, John Munkhaugen
Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial. European heart journal. Cardiovascular pharmacotherapy 7 (6) (2022)
Elise Sverre, K Peersen, J Perk, E Husebye, L Gullestad, T Dammen, J E Otterstad, J Munkhaugen
Challenges in coronary heart disease prevention - experiences from a long-term follow-up study in Norway. Scandinavian cardiovascular journal : SCJ 55 (2) (2020)
Elise Sverre, K Peersen, H Weedon-Fekjær, J Perk, E Gjertsen, E Husebye, L Gullestad, T Dammen, J E Otterstad, J Munkhaugen
Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population. BMC cardiovascular disorders 20 (1) (2020)
Elise Sverre, Jan Erik Otterstad, Erik Gjertsen, Lars Gullestad, Einar Husebye, Toril Dammen, Torbjørn Moum, John Munkhaugen
Medical and sociodemographic factors predict persistent smoking after coronary events. BMC cardiovascular disorders 17 (1) (2017)
Elise Sverre, Kari Peersen, Einar Husebye, Erik Gjertsen, Lars Gullestad, Torbjørn Moum, Jan Erik Otterstad, Toril Dammen, John Munkhaugen
Unfavourable risk factor control after coronary events in routine clinical practice. BMC cardiovascular disorders 17 (1) (2017)